Pfizer

NYVEPRIA - Cost

Last Updated: April 1st, 2024

HCPCS:

Q5122

HCPCS Code Descriptor:

Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg

Medicare Payment Limit:

The NYVEPRIA Medicare Payment Limit is $65.506

Average Sale Price:

NYVEPRIA ASP cost available once logged in. Nyvepria is a biosimilar drug making the ASP calculation more complex. Nyvepria's ASP is based on the average sale price of its biosimilar reference drug.

Medicare Co-Insurance Percentage:

The NYVEPRIA Medicare Co-insurance percentage is 20%. NYVEPRIA's Medicare Co-insurance amount is $13.1 per HCPCS unit.

APC Code:

The Nyvepria APC Code is: 9406

APC Payment Limit:

The APC Payment Limit for NYVEPRIA is available. Login to view.

Nyvepria Cost Information:

Nyvepria is a pegfilgrastim biosimilar mapped to the HCPCS Code: Q5122. Neulasta is the reference product for pegfilgrastim biosimilars. Neulasta’s list pricing has remained steady since its release, however, it’s ASP has been steadily dropping since April of 2021. As of quarter one 2024, Neulasta’s ASP is down by roughly 80% since it was first published in 2021.

ACCESS PRICING AND MORE BY REGISTERING

Nyvepria’s wholesale acquisition cost (WAC) information was last updated on:
November 30, 2020
Nyvepria’s average wholesale price (AWP) information was last updated on:
November 30, 2020